TrialThe oncologist2018

Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater.

Pat Gulhati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.